Company: XAIR
Filing Date: 2025-06-20
Form Type: 10-K
Source: 0001641172-25-015750
Chunk: 806

Company: Beyond Air, Inc.
Filing Date: 2025-06-20
Form: 10-K
Item: Item 1A
Chunk 806
---
 systems of certain countries,
particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property protection,
particularly those relating to biotechnology products, which could make it difficult for us to stop the infringement of our patents or
marketing of competing products in violation of our proprietary rights generally. Proceedings to enforce our patent rights in foreign
jurisdictions, whether or not successful, could result in substantial costs and divert our efforts and attention from other aspects of
our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing
and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other
remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around
the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.

65

Risks Related to Our Business Operations

We manage our business through a small number
of employees and key consultants.

As of March 31, 2025, we had a
total of 61 full-time employees between us and our subsidiaries and a number of dedicated consultants, all of whom work for us on a part-time
basis. In addition, any of our employees and consultants may leave the Company at any time, subject to certain notice periods. The loss
of the services of any of our executive officers or any key employees or consultants would adversely affect our ability to execute our
business plan and harm our operating results.

We do not currently carry “key
person” insurance on the lives of members of management.

We may need to expand our organization and we
may experience difficulties in recruiting needed additional employees and consultants, which could disrupt our operations.

As our development and commercialization
plans and strategies develop, we may need additional managerial, operational, sales, marketing, financial, legal and other resources.
The competition for qualified personnel in the life sciences field is intense. Due to this intense competition, we may be unable to attract
and retain qualified personnel necessary for the development of our business or to recruit suitable replacement personnel. We may experience
difficulty retaining and motivating existing employees and attracting qualified personnel to fill key positions. In addition, labor shortages
and employee mobility may make it more difficult to hire and retain employees.

Our management may need to divert
a disproportionate amount of its attention away from our day-to-day activities and devote a substantial amount of time to